Cargando…

Enteral Vancomycin to Eliminate MRSA Carriership of the Digestive Tract in Critically Ill Patients

Background: Carriership with methicillin resistant Staphylococcus aureus (MRSA) is a risk for the development of secondary infections in critically ill patients. Previous studies suggest that enteral vancomycin is able to eliminate enteral carriership with MRSA. Data on individual effects of this tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buitinck, Sophie H., Koopmans, Matty, Determann, Rogier M., Jansen, Rogier R., van der Voort, Peter H. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868137/ https://www.ncbi.nlm.nih.gov/pubmed/35203865 http://dx.doi.org/10.3390/antibiotics11020263

Ejemplares similares

Eradication of Resistant and Susceptible Aerobic Gram-Negative Bacteria From the Digestive Tract in Critically Ill Patients; an Observational Cohort Study
por: Buitinck, Sophie H., et al.
Publicado: (2022)

The ecological effects of selective decontamination of the digestive tract (SDD) on antimicrobial resistance: a 21-year longitudinal single-centre study
por: Buitinck, Sophie, et al.
Publicado: (2019)

Vancomycin resistance among MRSA
por: Kumar, V. Anil
Publicado: (2012)

Significance of Gram's Stain in Rapid Intrapartum Screening for Maternal Carriership of Group B Streptococcus
por: Adriaanse, Albert H., et al.
Publicado: (1995)

Pharmacist-Driven MRSA Nasal PCR Screening and the Duration of Empirical Vancomycin Therapy for Suspected MRSA Respiratory Tract Infections
por: Woolever, Nathan L., et al.
Publicado: (2020)

Time to acquire and lose carriership of ESBL/pAmpC producing E. coli in humans in the Netherlands
por: Teunis, Peter F. M., et al.
Publicado: (2018)

Correction: Time to acquire and lose carriership of ESBL/pAmpC producing E. coli in humans in the Netherlands
por: Teunis, Peter F. M., et al.
Publicado: (2018)

Ventilator-associated pneumonia in critically-ill patients with COVID-19 in a setting of selective decontamination of the digestive tract
por: van der Meer, Sinta B., et al.
Publicado: (2021)

78. Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Screen on Vancomycin Utilization for Respiratory Tract Infections
por: Debnath, Ashita, et al.
Publicado: (2021)

Cystic fibrosis carriership and tuberculosis: hints toward an evolutionary selective advantage based on data from the Brazilian territory
por: Bosch, Lander, et al.
Publicado: (2017)

Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
por: Graber, Christopher J., et al.
Publicado: (2007)

Reduced vancomycin susceptibility in porcine ST9 MRSA isolates
por: Kwok, Gabriella M. L., et al.
Publicado: (2013)

Acute MRSA Sinusitis with Intracranial Extension and Marginal Vancomycin Susceptibility
por: Kumar, Parvathi S., et al.
Publicado: (2013)

Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients
por: Determann, Rogier M, et al.
Publicado: (2010)

Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections
por: Neoh, Hui-min, et al.
Publicado: (2007)

Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA
por: Bhise, Ketki, et al.
Publicado: (2018)

474 Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
por: Pettit, Natasha, et al.
Publicado: (2014)

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia
por: Kamath, Meghan, et al.
Publicado: (2021)

160. Measuring the Impact of PCR-based MRSA Nares Screening on Vancomycin Use and Duration of Vancomycin Among Pneumonia Patients at an Academic Medical Center
por: Stromberg, Joseph, et al.
Publicado: (2023)

Impact of Vancomycin-Associated Acute Kidney Injury on Patient Outcomes in MRSA Bacteremia
por: Luther, Megan, et al.
Publicado: (2017)

Comparison of Outcomes in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin vs. Non-Vancomycin Anti-MRSA Therapy
por: Stoneking, Carolyn, et al.
Publicado: (2017)

The digestive tract as the origin of systemic inflammation
por: de Jong, Petrus R., et al.
Publicado: (2016)

Impact of Fecal Microbiota Transplantation on Digestive Tract Colonization due to Carbapenem-resistant Enterobacteriacae and Vancomycin-resistant Enterococci
por: Davido, Benjamin, et al.
Publicado: (2017)

The Effects of Fasting and Massive Diarrhea on Absorption of Enteral Vancomycin in Critically Ill Patients: A Retrospective Observational Study
por: Oami, Takehiko, et al.
Publicado: (2017)

Selective decontamination of the digestive tract (SDD) in critically ill patients: a narrative review
por: Wittekamp, Bastiaan H. J., et al.
Publicado: (2019)

Carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is a risk factor for ALS in the Finnish population
por: Kaivola, Karri, et al.
Publicado: (2020)

Carriership of the rs113883650/rs2287120 haplotype of the SLC7A5 (LAT1) gene increases the risk of obesity in infants with phenylketonuria
por: Bik-Multanowski, Miroslaw, et al.
Publicado: (2020)

Observation of “Seesaw Effect” with Vancomycin, Teicoplanin, Daptomycin and Ceftaroline in 150 Unique MRSA Strains
por: Barber, Katie E., et al.
Publicado: (2014)

Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients
por: Fernández-Barat, Laia, et al.
Publicado: (2019)

The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy
por: Morrisette, Taylor, et al.
Publicado: (2020)

Gut colonization with vancomycin-resistant Enterococcus and risk for subsequent enteric infection
por: Axelrad, Jordan E., et al.
Publicado: (2018)

673 Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation
por: Moise, Pamela, et al.
Publicado: (2014)

Selective decontamination of the digestive tract reduces mortality in critically ill patients
por: Schultz, Marcus J, et al.
Publicado: (2003)

Serum levels of N–terminal proB–type natriuretic peptide in mechanically ventilated critically ill patients – relation to tidal volume size and development of acute respiratory distress syndrome
por: Determann, Rogier M, et al.
Publicado: (2013)

Association between Accessory Gene Regulator Polymorphism and Mortality among Critically Ill Patients Receiving Vancomycin for Nosocomial MRSA Bacteremia: A Cohort Study
por: Cechinel, Angélica, et al.
Publicado: (2016)

Colonization and infection by MRSA in critically ill patients
por: Lorente, L, et al.
Publicado: (2007)

Enteric Viruses Nucleic Acids Distribution along the Digestive Tract of Rhesus Macaques with Idiopathic Chronic Diarrhea
por: Delwart, Eric, et al.
Publicado: (2022)

The Efficacy and Safety of Arbekacin and Vancomycin for the Treatment in Skin and Soft Tissue MRSA Infection: Preliminary Study
por: Hwang, Ji-Hee, et al.
Publicado: (2013)

A Rare Case of Methicillin-Resistant Staphylococcus aureus (MRSA) Enterocolitis Treated With Oral Vancomycin
por: Tagliaferri, Ariana R, et al.
Publicado: (2021)

Combining bacteriophage and vancomycin is efficacious against MRSA biofilm-like aggregates formed in synovial fluid
por: Taha, Mariam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lruto6avkjgm00chjgvhnjgcf4